The Aspirin-maker can’t shake off recent mistakes | DW Business

It’s one of Europe’s major industrial players, but Bayer continues to struggle. It’s takeover of controversial seed- and chemicals-giant Monsanto in 2018 saddled it with billions in legal fees and payments from the pesticide known as "Roundup." New court judgments added to its woes this year – Bayer stock is down 30 percent from the beginning of 2023. Investors are growing restless.

Chapters:

0:00 Background on Bayer
1:22 Rolf Fricker, Oliver Wyman Strategy Advisors

Subscribe: https://www.youtube.com/user/deutsche...

For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook:   / deutschewellenews  
►Twitter:   / dwnews  
►Instagram:   / dwnews  
►Twitch:   / dwnews_hangout  
Für Videos in deutscher Sprache besuchen Sie:    / dwdeutsch  
#bayer #aspirin #monsanto